Low-density subculture: A technical note on the importance of avoiding cell-to-cell contact during mesenchymal stromal cell expansion

Journal of Tissue Engineering and Regenerative Medicine

Volumn 9, Issue 10, 2015, Pages 1200-1203

  Balint, Richard ^a   Richardson, Stephen M ^a   Cartmell, Sarah H ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Culture; Expansion; Low confluence; Mesenchymal stromal cells; Proliferation

Indexed keywords

CELL ENGINEERING; CYTOLOGY; EXPANSION; TISSUE ENGINEERING;

CELL CONTACTS; CELL-SIZE; CONDITION; CULTURE; INFORMATION PROTOCOLS; LOW CONFLUENCE; LOWER DENSITY; MESENCHYMAL STROMAL CELLS; PROLIFERATION; PROLIFERATION RATE;

CELLS;

ENDOGLIN; MESSENGER RNA; CULTURE MEDIUM; LEUKOCYTE ANTIGEN;

ADIPOCYTE; ANTIGEN EXPRESSION; ARTICLE; CARTILAGE CELL; CELL CONTACT; CELL CULTURE; CELL DIFFERENTIATION; CELL EXPANSION; CELL GROWTH; CELL LINEAGE; CELL POPULATION; CELL PROLIFERATION; CELL RENEWAL; CELL SIZE; HUMAN; IMMUNOPHENOTYPING; MESENCHYMAL STROMA CELL; OSTEOBLAST; PRIORITY JOURNAL; SENESCENCE; CELL COMMUNICATION; CELL CULTURE TECHNIQUE; CULTURE MEDIUM; CYTOLOGY; IMMUNOLOGY; VIRUS CULTURE;

ANTIGENS, CD; CELL COMMUNICATION; CELL CULTURE TECHNIQUES; CULTURE MEDIA; MESENCHYMAL STROMAL CELLS; SERIAL PASSAGE;

EID: 84944513312     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.2051     Document Type: Article

References (18)

1. Ankrum J, Karp JM 2010; Mesenchymal stem cell therapy: two steps forward, one step back. Trends Mol Med 4: 203-209.
2. Apel A, Groth A, Schlesinger S, et al. 2009; Suitability of human mesenchymal stem cells for gene therapy depends on the expansion medium. Exp Cell Res 315: 498-507.
3. Banfi A, Muraglia A, Dozin B, et al. 2000; Proliferation kinetics and differentiation potential of ex vivo expanded human bone marrow stromal cells: implications for their use in cell therapy. Exp Hematol 28: 707-715.
4. Bartmann C, Rohde E, Schallmoser K, et al. 2007; Two steps to functional mesenchymal stromal cells for clinical application. Transfusion 47: 1426-1435.
5. Bernardo ME, Zaffaroni N, Novara F, et al. 2007; Human bone marrow-derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms. Cancer Res 67: 9142-9149.
6. Bonab MM, Alimoghaddam K, Talebian F, et al. 2006; Aging of mesenchymal stem cell in vitro. BMC Cell Biol 7: 1-7.
7. Chang J, Lei H, Liu Q, et al. 2012; Optimization of culture of mesenchymal stem cells: a comparison of conventional plate and microcarrier cultures. Cell Prolif 45: 430-437.
8. Colter D, Class R, DiGirolamo C, et al. 2000; Rapid expansion of recycling stem cells in cultures of plastic-adherent cells from human bone marrow. Proc Natl Acad Sci U S A 97: 3213-3218.
9. Colter DC, Sekiya I, Prockop DJ 2001; Identification of a subpopulation of rapidly self-renewing and multipotential adult stem cells in colonies of human marrow stromal cells. Proc Natl Acad Sci U S A 98: 7841-7845.
10. DiGirolamo CM, Stokes D, Colter D, et al. 1999; Propagation and senescence of human marrow stromal cells in culture: a simple colony-forming assay identifies samples with the greatest potential to propagate and differentiate. Br J Haematol 107: 275-281.
11. Gregory CA, Prockop DJ, Spees JL 2005; Non-hematopoietic bone marrow stem cells: molecular control of expansion and differentiation. Exp Cell Res 306: 330-335.
12. Jung S, Panchalingam KM, Rosenberg L, et al. 2012; Ex vivo expansion of human mesenchymal stem cells in defined serum-free media. Stem Cells Int 2012: 1-21.
13. Lepperdinger G, Brunauer R, Jamnig A, et al. 2008; Controversial issue: is it safe to employ mesenchymal stem cells in cell-based therapies? Exp Gerontol 43: 1018-1023.
14. Phinney D, Kopen G, Righter W, et al. 1999; Donor variation in the growth properties and osteogenic potential of human marrow stromal cells. J Cell Biochem 75: 424-436.
15. Sekiya I, Larson BL, Smith JR, et al. 2002; Expansion of human adult stem cells from bone marrow stroma: conditions that maximize the yields of early progenitors and evaluate their quality. Stem Cells 20: 530-541.
16. Siddappa R, Licht R, Blitterswijk C, et al. 2007; Donor variation and loss of multipotency during in vitro expansion of human mesenchymal stem cells for bone tissue engineering. J Orthop Res 25: 1029-1041.
17. Smith JR, Pochampally R, Perry A, et al. 2004; Isolation of a highly clonogenic and multipotential subfraction of adult stem cells from bone marrow stroma. Stem Cells 22: 823-831.
18. Sotiropoulou P, Perez S, Salagianni M, et al. 2006; Characterization of the optimal culture conditions for clinical scale production of human mesenchymal stem cells. Stem Cells 24: 462-471.